1-1 of 1
Giovanni Rindone
Close
Sort by
Journal Articles

A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK + lymphomas

Giovanni Rindone, Andrea Aroldi, Elisa Bossi, Luisa Verga, Giovanni Zambrotta, Sara Tarantino, Rocco Piazza, Lara Mussolin, Roberto Chiarle, Carlo Gambacorti-Passerini
Journal: Blood Advances
Blood Adv (2023) 7 (3): 314–316.
https://doi.org/10.1182/bloodadvances.2022007538
Published: 2023
Includes: Supplemental data